HPE
54
2
LLY
84
5
DVA
61
2
VNO
57
3
RSG
73
3
PSA
51
-2
JWN
57
-2
AMG
52
-2
PPL
82
-2
INTU
70
9
ROP
62
2
NRG
64
-11
NWS
96
4
AMAT
52
2
AA
34
-3
VZ
52
-2
CVX
44
3
HP
32
2
BAC
51
-2
PRGO
32
5
HPE
54
2
LLY
84
5
DVA
61
2
VNO
57
3
RSG
73
3
PSA
51
-2
JWN
57
-2
AMG
52
-2
PPL
82
-2
INTU
70
9
ROP
62
2
NRG
64
-11
NWS
96
4
AMAT
52
2
AA
34
-3
VZ
52
-2
CVX
44
3
HP
32
2
BAC
51
-2
PRGO
32
5
Financhill
Back

Vaxcyte Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

PCVX
Vaxcyte

Last Price:
$32.94
Seasonality Move:
13.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 25.7% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $32.92. The Score for PCVX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PCVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 25.7% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Sell
40
Vaxcyte (PCVX) is a Sell

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
27.66

Prediction Charts

Market Cap:
4.2B
Price in USD:
32.92
Volume:
1.6M
Beta:
1.28

Technical Analysis

SMA50:
59.15
SMA100:
73.41
SMA200:
84.95
52-Wk Change:
-45.19%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 32.92 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 30.58 32.51 34.11 30.50
Apr-8 33.05 30.20 33.75 28.46
Apr-9 30.11 30.80 32.45 27.80
Apr-10 29.39 28.04 30.48 27.66
Apr-11 27.97 31.20 31.31 27.80
Apr-14 32.15 32.04 32.50 31.05
Apr-15 32.19 30.23 32.72 29.29
Apr-16 30.15 29.12 30.39 28.58
Apr-17 29.04 30.65 30.68 28.75
Apr-21 30.34 30.39 31.61 30.13
Apr-22 31.22 31.26 32.30 31.01
Apr-23 32.17 33.16 34.40 32.17
Apr-24 33.05 34.51 34.52 32.49
Apr-25 34.00 32.92 34.00 31.99

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.46 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.